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Age-related changes in cerebral blood flow (CBF), which carries necessary nutrients
to the brain, are associated with increased risk for mild cognitive impairment (MCI)
and Alzheimer’s disease (AD). Whether the association between CBF and cognition
is moderated by apolipoprotein E (ApoE) ε4 genotype, a known risk factor for AD,
remains understudied, with most research focusing on exploring brain regions in
which there are diagnostic group differences in CBF (i.e., cognitively normal vs. MCI
vs. AD). This study measured resting CBF via arterial spin labeling (ASL) magnetic
resonance imaging (MRI) and verbal memory functions using a composite score in
59 older adults with normal cognition (38 ε3; 21 ε4). Linear mixed effect models
were employed to investigate if the voxel-wise relationship between verbal memory
performance and resting CBF was modified by ApoE genotype. Results indicated
that carriers of the ApoE ε4 allele display negative associations between verbal
memory functions and CBF in medial frontal cortex, medial and lateral temporal cortex,
parietal regions, insula, and the basal ganglia. Contrarily, ε3 carriers exhibited positive
associations between verbal memory functions and CBF in medial frontal cortex,
thalamus, insula, and basal ganglia. Findings suggest that higher CBF was associated
with worse verbal memory functions in cognitively normal ε4 carriers, perhaps
reflecting dysregulation within the neurovascular unit, which is no longer supportive
of cognition. Results are discussed within the context of the vascular theory of AD
risk.
Keywords: cerebral blood flow, arterial spin labeling (ASL), normal aging, brain perfusion, apolipoprotein E
genotype (ApoE), verbal memory, cognition
INTRODUCTION
Normal aging is associated with decrements in cognitive function and changes in
markers of brain health, such as reductions in cerebral blood flow (CBF; Parkes et al.,
2004; Lu et al., 2011). CBF, the rate of delivery of arterial blood to the capillary bed
of a tissue, is a measure of brain metabolism and neural function. It can be reliably
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quantified using arterial spin labeling (ASL) magnetic resonance
imaging (MRI), with average CBF values approximating
50 mL/100 g of tissue per minute in humans (Buxton,
2009). Compared to young adults, older individuals show CBF
reductions between 18–28% (Popa-Wagner et al., 2013) at a rate
of decline of 0.45% per year (Parkes et al., 2004). Age-related
decreases in CBF (hypoperfusion) have been associated with
cognitive decline and the development of dementia, suggesting
that cerebrovascular mechanisms play an important role in brain
health and the sustenance of cognitive functions (Knopman and
Roberts, 2010; Popa-Wagner et al., 2013; Wierenga et al., 2014;
Montagne et al., 2015).
Previous studies investigating the associations between
cognition and global gray matter (GM) CBF in cognitively
normal older adults report mixed results, with some showing
positive associations using carotid and basilar arterial flow
measurements (Rabbitt et al., 2006) and others finding negative
correlations using continuous ASL MRI (Bertsch et al., 2009).
For example, Heo et al. (2010) used a flow-enhanced signal
intensity MRI technique to measure blood velocity and found
that hippocampal blood flow was positively associated with
spatial memory performance in older adults. Unfortunately,
CBF measurement was limited to the hippocampus only and
region of interest approaches do not allow for the detection of
regional differences in specific brain regions where cognitive
functions are directly correlated with CBF. A recent study
by Steffener et al. (2013) employed a voxel-wise approach
and found that CBF patterns related to memory scores were
characterized by relative increased CBF in the cerebellum and
middle orbital frontal lobe and relative decreased blood flow in
the hippocampus, temporal cortex, and postcentral gyrus using
ASL MRI, and that expression of the CBF pattern accounted
for 44.4% of the variance in memory scores. These research
findings are encouraging and warrant further investigation
of the direct associations between cognition and CBF and
their possible clinical implications for Alzheimer’s disease (AD)
prevention.
The possible moderating effects of AD risk on the
relationship between CBF and cognitive performance remain
understudied. Given emerging evidence suggesting that
age-related cerebrovascular dysfunction contributes to the
development of AD (Kelleher and Soiza, 2013) and that CBF
varies as a function of AD risk (Wierenga et al., 2012, 2013,
2014; Hays et al., 2016), a better understanding of how the
association between distinct cognitive functions and regional
CBF differs by AD risk status is necessary in order to identify
vascular mechanisms of cognitive decline. Presence of the
apolipoprotein E (ApoE) epsilon 4 (ε4) allele, which plays a role
in cerebrovascular integrity and increases AD risk by 3–8 fold
(Tai et al., 2016), has been shown to affect CBF in normal and
pathological aging. Although results have been inconsistent,
possibly due to the different methodologies employed to measure
CBF and cognition, it is clear that ApoE genotype is associated
with changes in CBF. For example, compared to non-carriers
of the ApoE ε4 allele, ε4 carriers have shown increased CBF
in the medial temporal lobes (Bangen et al., 2012), left lingual
gyrus (LG), precuneus (Wierenga et al., 2013), and the right
insula (Thambisetty et al., 2010) using ASL MRI (Bangen and
Wierenga) and oxygen 15-labeled water positron emission
tomography (PET - Thambisetty). Contrarily, areas that have
shown evidence of decreased CBF in cognitively normal ε4
carriers compared to non-carriers include the left middle
temporal gyrus (MTG), right inferior parietal lobe, right caudate
and precentral gyrus, and right insula using ASL MRI (Kim
et al., 2013). As can be seen, both increased and decreased CBF
has been found in the right insula in ε4 carriers, highlighting
inconsistencies in the literature, which could be explained by the
use of different methodologies employed to measure CBF (i.e.,
ASL MRI vs. PET).
Increased CBF in themedial temporal lobe of ApoE ε4 carriers
has been associated with better verbal and non-verbal memory
abilities and interpreted to represent a possible compensatory
mechanism for altered metabolism and/or increased demand
for oxygen and glucose due to changes in neuronal activity
(Bangen et al., 2012; Wierenga et al., 2012). These findings are
consistent with previous research suggesting that the progression
from preclinical AD to mild cognitive impairment (MCI)
and later AD manifestation is characterized by a pattern of
early hyperperfusion (increased CBF) needed to compensate
for cerebrovascular dysregulation, followed by hypoperfusion
(decreased CBF) once homeostasis can no longer be maintained
due to cerebrovascular changes (Ostergaard et al., 2013;
Wierenga et al., 2014). Yet, few studies have investigated whether
ApoE genotype differentially moderates the direct relationship
between cognitive performance and CBF (Bangen et al., 2012;
Wierenga et al., 2013) and to our knowledge, no study has
looked directly at this relationship using a voxel-wise approach
to determine if regionally-specific associations between cognitive
performance and CBF exist and are differentially affected by
AD risk.
The current study used ASL MRI to investigate regions
in which there was a direct relationship between CBF
and verbal memory functions, and whether this association
was modified by genetic risk for AD (ApoE genotype) in
normal cognitive aging. We hypothesized that the direct
association between verbal memory functions and CBF would be
modified by ApoE genotype within regions known to subserve
memory functions (prefrontal, postero-medial, temporal, and
thalamus), consistent with previous reports (Grasby et al.,
1993; Wierenga et al., 2012, 2013). This study differs from
previous investigations since we do not seek to characterize
a diagnostic group (cognitively normal vs. MCI) by ApoE
(ε4 carrier vs. non-carrier) interaction on CBF, but rather
investigate the moderating role of ApoE genotype in the
association between CBF and verbal memory performance
within a group of cognitively normal older adults, using a voxel-
wise approach.
MATERIALS AND METHODS
Participants
See Table 1 for participant demographic and cognitive
characteristics. Participants were community-dwelling
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TABLE 1 | Participant demographic and cognitive characteristics.
APOE− (N = 38) APOE+ (N = 21)
Mean SD Mean SD df p
Age∗ 72.03 5.17 74.71 7.37 31.1 0.16
Education 16.47 2.42 16.00 2.14 57 0.428
Gender 27 female – 15 female – 1 0.743
DRS total score 140.92 2.44 141.24 1.9 57 0.586
Whole brain rCBF∗ 74.04 20.49 77.3 18.57 44.96 0.543
Verbal memory composite
WMS-R LM immediate recall 30.66 6.52 30.38 6.25 57 0.86
WMS-R LM delayed recall 28.76 6.89 27.14 7.81 57 0.444
CVLT-2 list 1–5 total 52.84 9.27 50.81 10.59 57 0.465
CVLT-2 SD free recall 11.58 2.96 10.33 3.12 57 0.152
CVLT-2 LD free recall 12.34 2.59 11.57 3.17 57 0.317
ApoE, Apolipoprotein E; DRS, Mattis Dementia Rating Scale; rCBF, Resting Cerebral Blood Flow; D-KEFS, Delis-Kaplan Executive Function System; CW, Color Word;
WMS-R, Wechsler Memory Scale-Revised; LM, Logical Memory; CVLT-2, California Verbal Learning Test-2; SD, Short Delay; LD, Long Delay; df, degrees of freedom for
independent samples T-test. ∗Denotes equal variances not assumed (df reported are adjusted for unequal variances).
older adult volunteers who were enrolled in a longitudinal
study of aging and/or other ongoing research studies at
the University of California San Diego (UCSD) and the
VA San Diego Healthcare System (VASDHS). Fifty nine
participants between the ages of 65 and 88 (mean age = 72.9,
SD = 6.1) were included in the current analyses, out of
which 38 were non-ApoE ε4 carriers (ApoE−), while 21
were ApoE ε4 carriers (ApoE+). Normal cognitive function
was determined using the empirically-derived criteria for
diagnosis of MCI developed by Jak et al. (2009), whereby
individuals were classified as cognitively normal if, at most,
performance on one measure within one or two cognitive
domains fell more than one standard deviation (SD)
below age-appropriate norms. All participants underwent
buccal swab DNA extraction for ApoE genotyping, a
comprehensive neuropsychological evaluation to determine
cognitive status and cognitive composite scores, and an MRI
examination.
Potential participants were excluded if they had dementia
or MCI, a history of severe head injury, uncontrolled
hypertension, were carriers of the ApoE ε2 allele, or had
a Diagnostic and Statistical Manual of Mental Disorders-
Fourth Edition Axis I diagnosis of learning disability,
attention deficit disorder, mood disorder, or substance
abuse. Persons with significant cerebrovascular disease,
defined by Framingham Stroke Risk Profile (D’Agostino
et al., 1994) 10-year probability of stroke >30%, or a
history of frank stroke or coronary artery disease were
excluded. In addition, participants were excluded if they had
contraindications to MRI scans such as ferrous implants
or a pacemaker, or if they were taking prescription
psychoactive medications. No participant reported a
significant level of depressive symptoms on the Geriatric
Depression Scale (i.e., GDS > 10). All participants provided
written informed consent prior to enrollment, and data
were collected in accordance with all Ethical standards
as stipulated by the Declaration of Helsinki and the
UCSD and VASDHS institutional review board-approved
procedures.
Neuropsychological Assessment and
Cognitive Composites
To examine the moderating role of ApoE genotype on the
association between cognitive function and CBF, a verbal
memory composite score was created using raw scores from tests
described in Table 1. These tests were selected based on results
from a principal component analysis previously reported by our
group on a similar sample of older adults (Wierenga et al., 2012).
Composite scores were derived by averaging the z-scores for each
of the tests within the composite.
Apolipoprotein E Genotyping
Genotyping for ApoE alleles was performed by the ADCS
Biomarker Core at UCSD using real time PCR Restriction
Fragment Length Polymorphism analysis. Genomic DNA was
collected from participants using buccal swab and extracted
using Qiamp DNA blood mini kit (Qiagen) followed by PCR
amplification (Wierenga et al., 2012).
MRI Acquisition
Imaging data were acquired on a GE Discovery MR750 3T
whole body system with a body transmit coil and an 8-channel
receive-only head coil at the University of California, San
Diego’s Center for functionalMRI. The structural brain sequence
consisted of a high-resolution T1-weighted Fast Spoiled Gradient
Recall (3D FSPGR) scan: 172 1 mm contiguous sagittal slices,
field of view (FOV) = 25 cm, repetition time (TR) = 8 ms,
echo time (TE) = 3.1 ms, flip angle = 12, inversion time
(TI) = 600 ms, 256 × 192 matrix, Bandwidth = 31.25 kHZ,
frequency direction = S-I, NEX = 1, scan time = 8 min
and 13 s. Resting CBF was acquired with the Multiphase
Pseudocontinuous Arterial Spin Labeling (MPPCASL) sequence,
which is optimized for robust CBF quantification (Jung et al.,
2010): tagging duration = 2 s, TI = 3.6 s, TR = 4.2 s,
TE = minimum, reps = 64, FOV = 22 × 22 cm, 20 5 mm
axial slices with a single shot spiral acquisition, collecting
eight cycles where each cycle consists of eight images acquired
with unique phase offsets, acquisition time (TA) = 4:46 min.
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A spiral scan with a long TR (4000 ms) and short TE
(3.4 ms) was also acquired to obtain an estimate of the
equilibrium magnetization of cerebral spinal fluid, which is
used to convert the perfusion signal into calibrated CBF units
(mL blood/100 g tissue/min). Finally, a minimum contrast
image was acquired to adjust for transmit and receive coil
inhomogeneities. Two field map scans were also acquired and
used for off-line field map correction to help correct for
signal bunching and dropouts in the frontal/medial temporal
lobes.
MRI Pre-Processing
Image processing was performed with Analysis of Functional
NeuroImages (AFNI1; Cox, 1996), FMRIB Software Library (FSL,
Oxford, UK), and locally created Matlab scripts. Field map
correction was applied to the ASL time series prior to co-
registration to the middle time point to minimize the effects
of participant motion. For each participant, a mean ASL image
was formed from the average difference of the control and tag
images using surround subtraction to create an uncorrected
perfusion time series, and slice timing delays were accounted for,
making the inversion time (TI2) slice specific (Liu and Wong,
2005). This mean ASL image was then converted to absolute
units of CBF (mL/100 g tissue/min) using an estimate of the
equilibrium magnetization of cerebrospinal fluid (CSF) as a
reference signal (Chalela et al., 2000). This procedure resulted in
a calibrated perfusion value for each voxel. Skull stripping of the
high-resolution T1-weighted image was performed using AFNI’s
3dSkullStrip. Scans were manually edited to remove residual
non-brain material when necessary. Tissue segmentation was
performed using FSL’s Automated Segmentation Tool (FAST)
algorithm to define CSF, GM and white matter (WM) regions.
The high-resolution T1-weighted image and partial volume
segmentations were registered to ASL space, and partial volume
segmentations were down-sampled to the resolution of the ASL
data. To correct the CBF measures for partial volume effects
and ensure that CBF values were not influenced by known
decreased perfusion in WM or increased volume of CSF (Parkes
et al., 2004), we used the method previously reported by Johnson
et al. (2005). These calculations assume that CSF has zero
CBF and that CBF in GM is 2.5× greater than that in WM.
The following formula was used to compute partial volume
corrected CBF signal intensities: CBFcorr = CBFuncorr/(GM
+ 0.4 ∗ WM). CBFcorr and CBFuncorr are corrected and
uncorrected CBF values, respectively. GM and WM are GM and
WM partial volume fractions, respectively. Information from
the high resolution structural image and the FSL FAST was
used to determine the tissue content of each perfusion voxel. A
4.0 mm full-width half-maximum (FWHM) Gaussian filter was
applied to the CBFcorr data. Voxels with negative intensities were
replaced with zero (Brown et al., 2003) and GM voxels were
thresholded at 0.9 probability. CBFcorr data were registered to
the MNI-152 atlas using FMRIB’s Non-linear Image Registration
Tool (FNIRT), part of FSL2 and resampled to a 3 × 3 × 3 mm
1afni.nimh.nih.gov
2http://fsl.fmrib.ox.ac.uk/fsl/
resolution grid. Data were then screened for quality and outlying
values deviating by more than three SDs from the mean were
eliminated.
Statistical Analyses
A voxel-wise linear mixed-effects (LME) regression model was
conducted in R with voxel-wise resting CBF as the dependent
variable and with independent variables: (1) verbal memory
composite score; (2) ApoE status (ε4 carrier vs. ε3 carrier); and
(3) the interaction term between verbal memory composite score
and ApoE status. Analyses were adjusted for the effects of age.
The LME yielded statistical maps displaying the brain regions
for which there were significant main effects of verbal memory
composite and APOE genotype on CBF and the interactive
effects of ApoE status and verbal memory composite on CBF.
Inferences are based on results of the ApoE status × verbal
memory composite interaction term only since we aim to
investigate in which brain regions there are moderating effects
of ApoE status on the association between verbal memory
and CBF. Significance was determined by applying cluster-size
correction derived from Monte-Carlo simulations (via AFNI’s
3dClustSim) to guard against false positives on data initially
thresholded at a value of p < 0.01 (uncorrected). Based on
these simulations, it was determined that a cluster size of 19
contiguous voxels (513 mm3) ensured an overall p < 0.01. To
characterize the direction of the interaction terms and obtain B
values for each ApoE group, post hoc regression analyses were
carried out using the mean CBF extracted from each significant
cluster resulting from the ApoE × verbal memory composite
interaction term. Post hoc analyses were conducted in IBM SPSS
Statistics, version 22 (bootstrapped with 1000 samples) and were
conducted only to characterize the significant LME interaction
terms.
RESULTS
ApoE groups did not differ significantly on age, years of
education, gender, Dementia Rating Scale (DRS) total score,
whole brain resting CBF, or on any of the cognitive tests that
comprised the verbal memory composite score (see Table 1).
Significant interactions between ApoE genotype and verbal
memory composite scores on CBF were found in nine clusters
within locations consistent with distributed verbal memory
processing (Grasby et al., 1993): right anterior cingulate cortex
(ACC), left thalamus, left hippocampus and parahippocampal
gyrus (PHG), left insula and putamen, left MTG, right putamen
and globus pallidus (GP; lenticular nucleus), right middle
and superior temporal gyrus (STG), left supramarginal gyrus
(SMG), and the left LG. Cluster locations with coordinates
and corresponding beta (B) values by ApoE genotype group
are listed on Table 2. Within these nine clusters there was a
trend for the ApoE+ genotype group to display overall lower
CBF than the ApoE− group (Figure 1), with significant group
differences in the left MTG (ApoE− mean CBF = 70.6, ApoE+
mean CBF = 58.2, p = 0.027) and the right middle and
STG (APOE− mean CBF = 70.4, APOE+ mean CBF = 51.8,
p= 0.011).
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TABLE 2 | Interactive effects of ApoE genotype and verbal memory on cerebral blood flow (CBF).
ApoE × verbal memory composite cluster locations ApoE− ApoE+
Mean cerebral blood flow in: Voxels X Y Z Max F-value B p B p
R Anterior cingulate 77 12 45 −3 20.2 11.1 0.031 −16.2 0.018
L Thalamus 60 −15 −18 0 14.3 12.5 0.014 −3.3 0.394
L Hc & PHG 49 −27 −42 −12 17.0 6.1 0.135 −13.6 0.002
L Insula & putamen 36 −30 3 12 16.4 11.1 0.015 −9.8 0.022
L MTG 34 −51 −30 −6 14.9 6.4 0.068 −18.9 0.001
R Putamen and GP 30 27 −9 −6 15.1 11.9 0.014 −5.0 0.411
R MTG and STG 28 54 −12 −12 14.6 7.3 0.142 −16.5 0.009
L SMG 25 −54 −27 18 13.5 7.3 0.055 −13.7 0.003
L Lingual gyrus 19 −6 −66 6 13.1 8.8 0.085 −10.0 0.273
CBF, Cerebral blood flow; L, Left; R, Right; X, Y, and Z coordinates represent the peak F-value in MNI space; Hc, Hippocampus; PHG, Parahippocampal gyrus; MTG,
Middle temporal gyrus; GP, Globus Pallidus; MTG, Middle temporal gyrus; STG, Superior temporal gyrus; SMG, Supramarginal gyrus.
FIGURE 1 | Apolipoprotein E (ApoE) group differences in mean cerebral
blood flow (CBF) in significant ApoE × verbal memory interaction
clusters. ∗Denotes significant ApoE group difference on CBF at p < 0.05.
Error bars denote the standard deviation of the mean. L, Left; R, Right; ACC,
Anterior cingulate cortex; Thal, Thalamus; Hc, Hippocampus; PHG,
Parahippocampal gyrus; Ins, Insula; Put, Putamen; MTG, Middle temporal
gyrus; GP, Globus pallidus; STG, Superior temporal gyrus; SMG,
Supramarginal gyrus; LG, Lingual gyrus.
Mean CBF was extracted from these nine significant clusters
to characterize the direction and magnitude of the interaction
effects. As can be seen in Figure 2, there is a consistent
pattern of positive associations between CBF and verbal memory
functions for those in the ApoE− group, whereas negative
associations between CBF and verbal memory functions are
observed for those in the ApoE+ group. As such, higher CBF
was associated with better verbal memory function for those
in the ApoE− group within the right ACC, left thalamus,
left insula and putamen, and the right lenticular nucleus.
Contrarily, higher CBF was associated with worse verbal memory
performance for those in the ApoE+ group within the right
anterior cingulate, left hippocampus and PHG, left insula and
putamen, left MTG, right middle and STG, and the left SMG
(see Table 2 for B-values and corresponding p-values). These
results indicate that the interaction between verbal memory
functions and ApoE genotype on CBF is characterized by positive
associations for ApoE ε3 carriers and negative associations
for ApoE ε4 carriers in medial frontal, medial temporal,
lateral temporal and parietal regions, as well as in subcortical
structures.
DISCUSSION
This study investigated whether ApoE genotype modified
the direct relationship between voxel-wise CBF and verbal
memory functions in a group of cognitively normal older
adults. Our methodology differs from previous studies in two
ways: (1) rather than using a region of interest approach,
we aimed to investigate in which brain regions there was a
significant ApoE × verbal memory performance interaction;
and (2) rather than comparing CBF in cognitively normal
individuals vs. those with MCI, and later examining the
associations between CBF in significant regions with cognitive
performance, we used verbal memory composite scores as a
direct predictor of voxel-wise CBF. We believe this approach
adds to the current literature by allowing us to extend previous
findings onto different brain regions in which ApoE genotype
may moderate the association between cognition and CBF.
Results suggest that the association between CBF and verbal
memory functions was modified by ApoE status in medial
frontal, medial temporal, lateral temporal and parietal regions,
as well as in subcortical structures. These interactions were
characterized by a consistent pattern of positive associations
between CBF and verbal memory functions in non-carriers
of the ApoE ε4 allele, whereas for those who carry the
ε4 allele, and are therefore at greater risk for developing
AD, there were negative associations between verbal memory
and CBF. Our findings suggest that, for those who are
not at genetic risk for AD, CBF supports verbal memory
functions, as expected, whereas for those carrying the ApoE ε4
allele, higher CBF is no longer supportive of verbal memory
functions.
These findings are surprising given previous reports
suggesting positive associations between CBF and cognition
in ApoE ε4 carriers, indicative of a compensatory strategy
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FIGURE 2 | Scatterplots characterizing the ApoE × verbal memory composite interaction on CBF in the nine significant clusters. Green represents the
ApoE+ group and blue represents the ApoE− group. Each significant cluster is depicted on the MNI152 standard brain to the right of its corresponding scatterplot.
CBF, Cerebral blood flow; PHG, Parahippocampal gyrus.
for those at risk for AD (Bangen et al., 2012; Wierenga et al.,
2012). These studies, however, investigated the association
between cognitive function and CBF for a-priori regions of
interest (Bangen et al., 2014) or for regions showing significant
diagnostic group (cognitively normal vs. MCI) differences in
CBF (Wierenga et al., 2012), rather than using a voxel-wise
approach to directly examine the relationship of CBF and
cognition. To our knowledge, this study represents the first
to show that, for cognitively normal individuals carrying
the ApoE ε4 allele, higher CBF does not seem to confer
or support better cognitive performance. Typically, higher
CBF should be beneficial to cognition since it provides
much needed oxygen and glucose in order to support
basic cognitive functions, as was the case for the ApoE ε3
carriers in this study. However, when there is damage to
the cerebral vasculature, as is commonly seen in ApoE ε4
carriers (Zlokovic, 2011; Bell et al., 2012), the brain may
no longer benefit from efficient use of these resources.
Animal studies have shown that neurovascular coupling,
the adjustment of CBF to meet the energetic demands of
activated neurons, is affected in aging leading to neurovascular
uncoupling. A recent study designed to pharmacologically
induce neurovascular uncoupling in young mice showed that
uncoupling itself was sufficient to cause cognitive deficiencies
and behavioral disturbances similar to those observed in
aging and pathophysiologic microvascular aging (Tarantini
et al., 2015). This uncoupling within the neurovascular
unit, due in part to dysregulation of production/release of
endothelial and neuronal nitric oxide, may help explain
why increased CBF in those at risk for AD (ApoE+ group)
was associated with poorer performance compared to the
ApoE− group. Moreover, studies have suggested that ApoE
ε4-induced detrimental cerebrovascular changes include
reduced CBF, modified neurovascular coupling, increased
blood–brain barrier (BBB) leakiness, cerebral amyloid
angiopathy, hemorrhages and disrupted transport of nutrients
and toxins (Tai et al., 2016), all of which affect cognitive
function.
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The current results support a vascular-focused theory of
AD risk (de la Torre, 2002; Zlokovic, 2011; Ostergaard et al.,
2013), which posits that cerebrovascular damage contributes to
cognitive decline and suggests that ApoE genotype modifies
the association between CBF and verbal memory in normal
aging. It is worth noting that these underlying cerebrovascular
changes are being observed in a group of individuals without
apparent cognitive impairment or clinical symptoms, further
highlighting that CBF changes occur pre-clinically and may
serve as an important biomarker of AD risk (Hays et al.,
2016).
Strengths and Limitations
This study was limited by a small sample size and by unbalanced
ApoE groups (64.4% ApoE− vs. 35.6% ApoE+) which may affect
the power to detect group differences. However, even with this
small sample size we were able to find regions of significant
interaction effects where the direction and magnitude of
associations were consistent across brain regions. Future studies
should include larger samples to replicate the current findings,
as well as include individuals with MCI, who are at increased
risk for AD. Furthermore, given the cross-sectional nature of
this study, we cannot ascertain whether vascular dysregulation in
ApoE ε4 carriers conferred worse verbal memory performance
or vice versa. Finally, the use of ASL MRI may posit certain
limitations, such as sensitivity to transit time effects, low spatial
resolution, less sensitivity to WM CBF, and lack of sequence
standardization across research centers, which may help to
explain discrepancies in the literature. Strengths of the current
study are: the inclusion of a well-characterized sample of older
adults, the use of non-invasive ASL MRI to measure CBF, the
availability of several cognitive test performances to characterize
cognitive status, and the use of voxel-wise linear mixed effects
models, which allowed us to examine the direct association
between verbal memory performance and CBF within the entire
brain.
CONCLUSION
This study demonstrates that ApoE ε4 genotype negatively
impacts or disrupts the relationship between CBF and verbal
memory functions in cognitively normal older adults, whereas
in non-carriers (ε3), higher CBF supported verbal memory
functions. Future longitudinal studies should examine changes
in CBF in cognitively normal individuals and in those with MCI
over time, taking into consideration that the association between
CBF and cognition may differ by ApoE status. Moreover,
intervention studies that target CBF to improve cognition in
aging should account for ApoE genotype, since differential
changes in CBF as a function of genetic risk may impact cognitive
effects.
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